New York, NY -- (SBWIRE) -- 01/16/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Extreme Networks, Inc (NASDAQ:EXTR), Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL), MediciNova, Inc (NASDAQ:MNOV)
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) showed a volume of 1.52 million shares by the end of last trade whereas the average volume of the stock remained 1.14 million shares. The stock opened the session at $6.74 but then moved to $6.97. At that price, the stock showed a positive performance of 4.19%. Idenix Pharmaceuticals, Inc. (Idenix) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. As of December 31, 2012, the Company's primary research and development focused on the treatment of patients with hepatitis C virus (HCV). In June 2012, the Company completed a three-day proof-of-concept study designed to evaluate 64 treatment-naive HCV genotype 1, 2, 3 or 4-infected patients.
Will IDIX Continue To Move Higher? Find Out Here
Extreme Networks, Inc (NASDAQ:EXTR) opened the session at $7.73 and closed the session at $7.82. The stock showed a positive performance of 1.56% in previous trading session. Extreme Networks, Inc. together with its subsidiaries, is a provider of network infrastructure equipment and services for enterprises, data centers, and service providers. The Company’s customers include businesses, hospitals, schools, hotels, telecommunications companies and government agencies globally.
For How Long EXTR will fight for Profitability? Read This Trend Analysis report
Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL) opened the session at $4.60 and closed the session at $4.65. The stock showed a positive performance of 0.43% in previous trading session. Traded with volume of 1.48 million shares in the prior session and the average volume of the stock remained 1.17 million shares. The beta of the stock remained 1.95. Gol Linhas Aereas Inteligentes SA (Gol) is a Brazil-based holding company primarily engaged in the passenger air transportation sector. Through its subsidiaries, such as VRG Linhas Aereas SA, GAC Inc and Gol Finance, the Company is involved in the provision of scheduled and non-scheduled passenger air transportation services, as well as cargo and mail bags freight air transportation.
Why Should Investors Buy GOL After The Recent Gain? Just Go Here and Find Out
MediciNova, Inc (NASDAQ:MNOV) the stock decreased -5.28% and finished the session at $2.69. Traded with volume of 1.50 million shares in the prior session and the average volume of the stock remained 308,066.00 shares. The beta of the stock remained 0.79. MediciNova, Inc. is a development-stage biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs with a focus on the United States market. Through strategic alliances, primarily with Japanese pharmaceutical companies, it holds rights to a diversified portfolio of clinical and preclinical product candidates.
Will MNOV Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)